DAH: Diffuse Alveolar Hemorrhage
Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) – a review of a new treatment paradigm
10
KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome
8
Clinical Features and Treatment Strategy of Vasculitis-Associated Diffuse Alveolar Hemorrhage
6
Diffuse Alveolar Hemorrhage in Pediatric Hematopoietic Cell Transplant Patients
9
INTERACTIVE CASE REPORT: Sevoflurane-related Isolated Pulmonary Vasculitis: A New Etiological Cause of Diffuse Alveolar Hemorrhage?
6
Successful management of warfarin-exacerbated diffuse alveolar hemorrhage using an extracorporeal membrane oxygenation
6
Diffuse alveolar hemorrhage in childhood-onset systemic lupus erythematosus: a severe disease flare with serious outcome
6
Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage in Children
7
High-dimensional analysis reveals a pathogenic role of inflammatory monocytes in experimental diffuse alveolar hemorrhage
16
Pre existing chronic interstitial pneumonia is a poor prognostic factor of Goodpasture’s syndrome: a case report and review of the literature
5
Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer
5
Click here to download PDF version of the article !
6
Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides
12
Case Report Diffuse alveolar damage in a patient with Epstein Barr virus (EBV)-positive diffuse large B-cell lymphoma, severely low serum folate, and megaloblastic anemia: a case report of autopsy
6
Recurrent Diffuse Alveolar Haemorrhage in a Patient with IgA Nephropathy Related End Stage Kidney Disease: A Rare Complication
6
The social network of international health aid
55
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
9
Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis
13
Clinical Reasoning: A 52-year-old man with spells of altered consciousness and severe headaches
7
A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab
5